These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 34250645)
1. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis. Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645 [TBL] [Abstract][Full Text] [Related]
2. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation. Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893 [TBL] [Abstract][Full Text] [Related]
3. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study. Myran DT; Brown CRL; Tanuseputro P CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593 [TBL] [Abstract][Full Text] [Related]
4. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation. Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811 [TBL] [Abstract][Full Text] [Related]
5. Legal cannabis market shares during Canada's first year of recreational legalisation. Armstrong MJ Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614 [TBL] [Abstract][Full Text] [Related]
6. Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation. Friesen EL; Konikoff L; Dickson S; Myran DT Drug Alcohol Rev; 2024 Nov; 43(7):1753-1763. PubMed ID: 38803128 [TBL] [Abstract][Full Text] [Related]
7. Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation. Fataar F; Driezen P; Owusu-Bempah A; Hammond D J Cannabis Res; 2024 Feb; 6(1):5. PubMed ID: 38351142 [TBL] [Abstract][Full Text] [Related]
8. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review. Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188 [TBL] [Abstract][Full Text] [Related]
9. Proximity to Legal Cannabis Stores in Canada and Use of Cannabis Sources in the First Three Years of Legalization, 2019-2021. Wadsworth E; Driezen P; Dilley JA; Gabrys R; Jesseman R; Hammond D J Stud Alcohol Drugs; 2023 Nov; 84(6):852-862. PubMed ID: 37306374 [TBL] [Abstract][Full Text] [Related]
10. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis. Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149 [TBL] [Abstract][Full Text] [Related]
11. Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada. Myran DT; Roberts R; Pugliese M; Taljaard M; Tanuseputro P; Pacula RL JAMA Netw Open; 2022 Sep; 5(9):e2231937. PubMed ID: 36112372 [TBL] [Abstract][Full Text] [Related]
12. Perceived access to cannabis and ease of purchasing cannabis in retail stores in Canada immediately before and one year after legalization. Wadsworth E; Driezen P; Chan G; Hall W; Hammond D Am J Drug Alcohol Abuse; 2022 Mar; 48(2):195-205. PubMed ID: 35157544 [No Abstract] [Full Text] [Related]
13. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019. Callaghan RC; Sanches M; Vander Heiden J; Kish SJ Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258 [TBL] [Abstract][Full Text] [Related]
14. The association between physical availability of cannabis retail outlets and frequent cannabis use and related health harms: a systematic review. Cantor N; Silverman M; Gaudreault A; Hutton B; Brown C; Elton-Marshall T; Imtiaz S; Sikora L; Tanuseputro P; Myran DT Lancet Reg Health Am; 2024 Apr; 32():100708. PubMed ID: 38486811 [TBL] [Abstract][Full Text] [Related]
15. Disparities in cannabis-related emergency department visits across depressed and non-depressed individuals and the impact of recreational cannabis policy in Ontario, Canada. Kim C; Dusing GJ; Nielsen A; MacMaster FP; Rittenbach K; Allin S; O'Campo P; Penney TL; Hamilton HA; Kirst M; Chum A Psychol Med; 2023 Nov; 53(15):7127-7137. PubMed ID: 37345465 [TBL] [Abstract][Full Text] [Related]
16. Cannabis use prior to legalisation among alcohol consumers in the Canadian Yukon and Northwest territories. Hammond D; Goodman S; Hobin E Int J Circumpolar Health; 2021 Dec; 80(1):1948254. PubMed ID: 34278981 [TBL] [Abstract][Full Text] [Related]
17. Retail availability and legal purchases of dried flower in Canada post-legalization. Wadsworth E; Driezen P; Hammond D Drug Alcohol Depend; 2021 Aug; 225():108794. PubMed ID: 34098382 [TBL] [Abstract][Full Text] [Related]
18. Noticing of cannabis health warning labels in Canada and the US. Goodman S; Hammond D Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418 [TBL] [Abstract][Full Text] [Related]
19. Non-medical cannabis in North America: an overview of regulatory approaches. Lancione S; Wade K; Windle SB; Filion KB; Thombs BD; Eisenberg MJ Public Health; 2020 Jan; 178():7-14. PubMed ID: 31600630 [TBL] [Abstract][Full Text] [Related]
20. Patterns of problematic cannabis use in Canada pre- and post-legalisation: Differences by neighbourhood deprivation, individual socioeconomic factors and race/ethnicity. Fataar F; Driezen P; Owusu-Bempah A; Hammond D Drug Alcohol Rev; 2023 Sep; 42(6):1534-1546. PubMed ID: 37137866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]